385
Views
38
CrossRef citations to date
0
Altmetric
Research Articles

Oxidative stress, as measured by protein oxidation, is increased in primary Sjøgren's syndrome

, , , , &
Pages 141-146 | Received 16 Aug 2011, Accepted 24 Nov 2011, Published online: 12 Jan 2012

References

  • Fox RI. Sjogren's syndrome. Lancet 2005;366:321–331.
  • Goransson L, Haldorsen K, Brun J, Harboe E, Jonsson M, Skarstein K, . The point prevalence of clinically relevant primary Sjogren's syndrome in two Norwegian counties. Scand J Rheumatol 2011;40:221–224.
  • Ramos-Casals M, Tzioufas AG, Font J. Primary Sjogren's syndrome: new clinical and therapeutic concepts. Ann Rheum Dis 2005;64:347–354.
  • Hansen A, Lipsky PE, Dorner T. B cells in Sjogren's syndrome: indications for disturbed selection and differentiation in ectopic lymphoid tissue. Arthritis Res Ther 2007;9:218. Review.
  • Meijer JM, Meiners PM, Huddleston Slater JJ, Spijkervet FK, Kallenberg GC, Vissnik A, . Health-related quality of life, employment and disability in patients with Sjogren's syndrome. Rheumatology 2009;48:1077–1082.
  • Bowman SJ. Patient-reported outcomes including fatigue in primary Sjogren's syndrome. Rheum Dis Clin North Am 2008;34:949–962.
  • Bjerrum K, Prause JU. Primary Sjogren's syndrome: a subjective description of the disease. Clin Exp Rheumatol 1990;8:283–288.
  • Brkic S, Tomic S, Maric D, Novakov Mikic A, Turkulov V. Lipid peroxidation is elevated in female patients with chronic fatigue syndrome. Med Sci Monit 2010;16:628–632.
  • Kennedy G, Spence VA, McLaren M, Hill A, Underwood C, Belch JJ. Oxidative stress levels are raised in chronic fatigue syndrome and are associated with clinical symptoms. Free Radic Biol Med 2005;39:584–589.
  • Avalos I, Chung CP, Oeser A, Milne GL, Morrow JD, Gebretsadik T, . Oxidative stress in systemic lupus erythematosus: relationship to disease activity and symptoms. Lupus 2007;16:195–200.
  • Chung CP, Titova D, Oeser A, Randels M, Avalos I, Milne GL, . Oxidative stress in fibromyalgia and its relationship to symptoms. Clin Rheumatol 2009;28:435–438.
  • Perricone C, De Carolis C, Perricone R. Glutathione: a key player in autoimmunity. Autoimmun Rev 2009;8:697–701.
  • Raffaello A, Rizzuto R. Mitochondrial longevity pathways. Biochim Biophys Acta 2011;1813:260–268.
  • West AP, Brodsky IE, Rahner C, Woo DK, Erdjument-Bromage H, Tempst P, . TLR signalling augments macrophage bactericidal activity through mitochondrial ROS. Nature 2011;472:476–480.
  • Wang G, Pierangeli SS, Papalardo E, Ansari GA, Khan MF. Markers of oxidative and nitrosative stress in systemic lupus erythematosus: correlation with disease activity. Arthritis Rheum 2010;62:2064–2072.
  • Cedergren J, Forslund T, Sundqvist T, Skogh T. Intracellular oxidative activation in synovial fluid neutrophils from patients with rheumatoid arthritis but not from other arthritis patients. J Rheumatol 2007;34:2162–2170.
  • Witherick J, Wilkins A, Scolding N, Kemp K. Mechanisms of oxidative damage in multiple sclerosis and a cell therapy approach to treatment. Autoimmune Dis 2010;2011:164608.
  • Gabrielli A, Avvedimento EV, Krieg T. Scleroderma. N Engl J Med 2009;360:1989–2003.
  • Ryo K, Yamada H, Nakagawa Y, Tai Y, Obara K, Inoue H, . Possible involvement of oxidative stress in salivary gland of patients with Sjogren's syndrome. Pathobiology 2006; 73:252–260.
  • Kurimoto C, Kawano S, Tsuji G, Hatachi S, Jikimoto T, Sugiyama D, . Thioredoxin may exert a protective effect against tissue damage caused by oxidative stress in salivary glands of patients with Sjögren's syndrome. J Rheumatol 2007;34:2035–2043.
  • Cejková J, Ardan T, Simonová Z, Cejka C, Malec J, Dotrelová D, . Decreased expression of antioxidant enzymes in the conjunctival epithelium of dry eye (Sjögren's syndrome) and its possible contribution to the development of ocular surface oxidative injuries. Histol Histopathol 2008;23:1477–1483.
  • Perl A, Fernandez DR, Telarico T, Doherty E, Francis L, Phillips PE. T-cell and B-cell signaling biomarkers and treatment targets in lupus. Curr Opin Rheumatol 2009;21:454–464.
  • Dalle-Donne I, Giustarini D, Colombo R, Rossi R, Milzani A. Protein carbonylation in human diseases. Trends Mol Med 2003;9:169–176.
  • Witko-Sarsat V, Friedlander M, Capeillere-Blandin C, Nguyen-Khoa T, Nguyen AT, Zingraff J, . Advanced oxidation protein products as a novel marker of oxidative stress in uremia. Kidney Int 1996;49:1304–1313.
  • Vitali C, Bombardieri S, Jonsson R, Moutsopoulos HM, Alexander EL, Carsons SE, . Classification criteria for Sjogren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 2002;61:554–558.
  • Beck AT, Beamesderfer A. Assessment of depression: the depression inventory. Mod Probl Pharmacopsychiatry 1974;7:151–169.
  • Krupp LB, LaRocca NG, Muir-Nash J, Steinberg AD. The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus. Arch Neurol 1989;46:1121–1123.
  • Levine RL. Mixed-function oxidation of histidine residues. Methods Enzymol 1984;107:370–376.
  • Goransson LG, Herigstad A, Tjensvoll AB, Harboe E, Mellgren SI, Omdal R. Peripheral neuropathy in primary Sjogren syndrome: a population-based study. Arch Neurol 2006;63:1612–1615.
  • Harboe E, Tjensvoll AB, Vefring HK, Goransson LG, Kvaloy JT, Omdal R. Fatigue in primary Sjogren's syndrome – a link to sickness behaviour in animals? Brain Behav Immun 2009;23:1104–1108.
  • Singh S, Vrishni S, Singh BK, Rahman I, Kakkar P. Nrf2-ARE stress response mechanism: a control point in oxidative stress-mediated dysfunctions and chronic inflammatory diseases. Free Radic Res 2010;44:1267–1288.
  • Seror R, Mariette X, Bowman S, Baron G, Gottenberg JE, . Accurate detection of changes in disease activity in primary Sjogren's syndrome by the European League Against Rheumatism Sjogren's Syndrome Disease Activity Index. Arthritis Care Res (Hoboken) 2010;62:551–558.
  • Young IS. Oxidative stress and vascular disease: insights from isoprostane measurement. Clin Chem 2005;51:14–15.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.